LINDSAY MCGOVERN: Open Payments
NPI 1053097451 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,609 in 131 payments from 17 companies in 2025. Trend: 2023 $715 · 2024 $1,213 · 2025 $2,609
Food & beverage: $2,351Education: $257
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $448 |
| UCB, Inc. | 17 | $332 |
| Janssen Biotech, Inc. | 13 | $325 |
| PFIZER INC. | 4 | $230 |
| Regeneron Healthcare Solutions, Inc. | 12 | $227 |
| GENZYME CORPORATION | 6 | $208 |
| Incyte Corporation | 11 | $152 |
| Galderma Laboratories, L.P. | 16 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Organon LLC | 3 | $80 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, CIBINQO, OPZELURA, NEMLUVIO, TALTZ.
Industry payments across MA — which companies pay providers there.
